Shappell SB - Search Results

1

Approaches to understanding the importance and clinical implications of peroxisome proliferator-activated receptor gamma (PPARgamma) signaling in prostate cancer.

Jiang M, Shappell SB, Hayward SW. Jiang M, et al. Among authors: shappell sb. J Cell Biochem. 2004 Feb 15;91(3):513-27. doi: 10.1002/jcb.10770. J Cell Biochem. 2004. PMID: 14755682 Review.

2

Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR, Hayward SW. Love HD, et al. Among authors: shappell sb. PLoS One. 2009 Dec 21;4(12):e8384. doi: 10.1371/journal.pone.0008384. PLoS One. 2009. PMID: 20027305 Free PMC article.

3

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ. Jin RJ, et al. Among authors: shappell sb. Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117. Cancer Res. 2004. PMID: 15289359

4

Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.

Ishii K, Shappell SB, Matusik RJ, Hayward SW. Ishii K, et al. Among authors: shappell sb. Lab Invest. 2005 Sep;85(9):1086-103. doi: 10.1038/labinvest.3700310. Lab Invest. 2005. PMID: 15980886 Free article.

5

Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.

Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ. Gao N, et al. Among authors: shappell sb. Development. 2005 Aug;132(15):3431-43. doi: 10.1242/dev.01917. Epub 2005 Jun 29. Development. 2005. PMID: 15987773

6

Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B, Yi Y, Magnuson MA, Roy-Burman P, Matusik RJ, Shappell SB, Hayward SW. Jiang M, et al. Among authors: shappell sb. Cell Death Differ. 2010 Mar;17(3):469-81. doi: 10.1038/cdd.2009.148. Epub 2009 Oct 16. Cell Death Differ. 2010. PMID: 19834493 Free PMC article.

7

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.

Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW. Wang Y, et al. Among authors: shappell sb. Prostate. 2005 Jul 1;64(2):149-59. doi: 10.1002/pros.20225. Prostate. 2005. PMID: 15678503

8

A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.

Mullins C, Lucia MS, Hayward SW, Lee JY, Levitt JM, Lin VK, Liu BC, Chinnaiyan AM, Rubin MA, Slawin K, Star RA, Getzenberg RH; MPSA Consortium. Mullins C, et al. J Urol. 2008 Apr;179(4):1243-56. doi: 10.1016/j.juro.2007.11.049. Epub 2008 Feb 20. J Urol. 2008. PMID: 18280515 Free PMC article. Review.

9

15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.

Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN. Shappell SB, et al. Cancer Res. 2001 Jan 15;61(2):497-503. Cancer Res. 2001. PMID: 11212240

10

Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.

Xu Y, Iyengar S, Roberts RL, Shappell SB, Peehl DM. Xu Y, et al. Among authors: shappell sb. J Cell Physiol. 2003 Jul;196(1):131-43. doi: 10.1002/jcp.10281. J Cell Physiol. 2003. PMID: 12767049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters